SCHEMBL5753239

SCHEMBL5753239

Fc1ccc(C2CCN(Cc3ccc4[nH]ccc4c3)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 1/20 0.58
MCHR1 Q99705 4/20 0.51
KCNH2 Q12809 3/20 0.51
MCHR2 Q969V1 2/20 0.51
FAAH O00519 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
DRD4 P21917 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
ACHE P22303 2/20 0.45
BCHE P06276 1/20 0.45
AHR P35869 1/20 0.44
PARP1 P09874 2/20 0.44
PARP2 Q9UGN5 1/20 0.44
HTR4 Q13639 1/20 0.43
CHRM1 P11229 2/20 0.43
CHRM5 P08912 1/20 0.43
CHRM3 P20309 1/20 0.43
TNIK Q9UKE5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755013 0.91 MCHR1 (0.50) SSTR5MCHR1KCNH2MCHR2FAAH
SCHEMBL7078098 0.88 MAPT (0.57) SSTR5MCHR1KCNH2MCHR2SIGMAR1
SCHEMBL5752080 0.88 MEN1 (0.58) SSTR5MCHR1FAAHSIGMAR1DRD4
SCHEMBL5751430 0.88 DRD4 (0.52) SSTR5MCHR1KCNH2MCHR2FAAH
SCHEMBL26134148 0.80 FAAH (0.55) SSTR5MCHR1KCNH2MCHR2FAAH
SCHEMBL5753042 0.80 MAPT (0.57) SSTR5MCHR1KCNH2MCHR2FAAH
SCHEMBL10556550 0.80 MEN1 (0.61) SIGMAR1ACHEBCHEDRD2
SCHEMBL5753083 0.79 DRD2 (0.53) MCHR1KCNH2MCHR2FAAHDRD4
SCHEMBL13293706 0.76 FAAH (0.55) FAAHSIGMAR1DRD4ROCK2
SCHEMBL22584711 0.75 LTA4H (0.63) MCHR1KCNH2MCHR2FAAHSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105543-B2 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders H. LUNDBECK A/S (DK) 2006-09-12 US claimed
US-7105543-B2 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders H. LUNDBECK A/S (DK) 2006-09-12 US disclosed
EP-1309586-B1 4-, 5-, 6- AND 7-INDOLE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS LUNDBECK & CO AS H (DK) 2006-03-22 EP disclosed
US-20060004022-A1 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders H. LUNDBECK A/S (DK) 2006-01-05 US disclosed
US-6958338-B2 4-,5-,6-and 7-indole derivatives useful for the treatment of CNS disorders H. LUNDBECK A/S (DK) 2005-10-25 US disclosed
US-20030166665-A1 4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders H. LUNDBECK A/S (DK) 2003-09-04 US disclosed
EP-1309586-A1 4-, 5-, 6- AND 7-INDOLE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS H. LUNDBECK A/S (DK) 2003-05-14 EP disclosed
WO-2002016349-A1 4-, 5-, 6- AND 7-INDOLE DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS H. LUNDBECK A/S (DK) 2002-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004022-A1 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders HTR3C, SLC6A3, HTR6 SSTR5 194/4885MCHR1 95/4885KCNH2 319/4885
US-20030166665-A1 4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders HTR3C, HTR6, SLC6A3 SSTR5 349/4885MCHR1 92/4885KCNH2 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.